EUVIMEDEUVIMED entdecken
Crossref

22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study

Ahmed Almezaine

Journal of Investigative Dermatology · 2025-11 · 145 (11) · e35

DOI: 10.1016/j.jid.2025.09.042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Investigative Dermatology, 2025-11. Verfasst von Ahmed Almezaine.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Almezaine, A. (2025). 22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study. Journal of Investigative Dermatology, 145(11), e35. https://doi.org/10.1016/j.jid.2025.09.042

Vancouver

Almezaine A. 22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study. Journal of Investigative Dermatology. 2025;145(11):e35. doi:10.1016/j.jid.2025.09.042

BibTeX
@article{Almezaine2025,
  author = {Almezaine, Ahmed},
  title = {22 Disparities in Non-Melanoma Skin Cancer Survival Among Patients with Immune-Mediated Inflammatory Diseases: A Population-Based Study},
  journal = {Journal of Investigative Dermatology},
  year = {2025},
  volume = {145},
  number = {11},
  pages = {e35},
  doi = {10.1016/j.jid.2025.09.042}
}
Kostenlos starten →